Dermata Therapeutics Inc Share Price Today: Live Updates & Key Insights
Dermata Therapeutics Inc share price today is $1.31, up 20.66%. The stock opened at $1.49 against the previous close of $1.21, with an intraday high of $1.84 and low of $1.37.
Dermata Therapeutics Inc Share Price Chart
Dermata Therapeutics Inc
Dermata Therapeutics Inc Share Price Performance
Dermata Therapeutics Inc Institutional Holdings
Dermata Therapeutics Inc Market Status
Dermata Therapeutics Inc Fundamentals
Market Cap 4.67 M
PB Ratio 1.0375
PE Ratio 0.0958
Enterprise Value -0.56 M
Total Assets 3.53 M
Volume 39595091
Dermata Therapeutics Inc Company Financials
About Dermata Therapeutics Inc & investment objective
Company Information Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its lead product candidate is XYNGARI, which is in Phase 3 clinical studies for the treatment of moderate-to-severe acne, as well as completed Phase 1b proof of concept (POC) trial for mild-to-moderate psoriasis. The company is also developing DMT410 that has completed Phase 1b POC trials for the treatment of axillary hyperhidrosis and aesthetic skin conditions. It has a clinical trial collaboration agreement with Revance Therapeutics, Inc. to conduct a multi-center clinical trial to evaluate the topical application of XYNGARI with DAXXIFY, Revance's botulinum toxin type A. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Organisation Biotechnology
Employees 8
Industry Biotechnology
CEO Mr. Gerald T. Proehl
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Dermata Therapeutics Inc FAQs
What is the share price of Dermata Therapeutics Inc today?
The current share price of Dermata Therapeutics Inc is $1.31.
Can I buy Dermata Therapeutics Inc shares in India?
Yes, Indian investors can buy Dermata Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Dermata Therapeutics Inc shares in India?
You can easily invest in Dermata Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Dermata Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Dermata Therapeutics Inc.
Can I buy fractional shares of Dermata Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Dermata Therapeutics Inc?
Dermata Therapeutics Inc has a market cap of $4.67 M.
In which sector does Dermata Therapeutics Inc belong?
Dermata Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Dermata Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Dermata Therapeutics Inc?
The PE ratio of Dermata Therapeutics Inc is 0.10 and the PB ratio is 1.04.